ProPhase Labs Inc (PRPH)
4.95
-0.11
(-2.17%)
USD |
NASDAQ |
Apr 25, 16:00
4.99
+0.04
(+0.81%)
After-Hours: 20:00
ProPhase Labs Cash from Investing (Quarterly): -1.264M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.264M |
| September 30, 2023 | 0.332M |
| June 30, 2023 | 1.215M |
| March 31, 2023 | -1.652M |
| December 31, 2022 | -5.003M |
| September 30, 2022 | -0.67M |
| June 30, 2022 | -0.488M |
| March 31, 2022 | 4.084M |
| December 31, 2021 | 5.484M |
| September 30, 2021 | -3.372M |
| June 30, 2021 | -14.95M |
| March 31, 2021 | -6.832M |
| December 31, 2020 | 2.658M |
| September 30, 2020 | -1.12M |
| June 30, 2020 | -2.532M |
| March 31, 2020 | -0.022M |
| December 31, 2019 | 2.787M |
| September 30, 2019 | 0.808M |
| June 30, 2019 | -0.474M |
| March 31, 2019 | 2.422M |
| December 31, 2018 | 0.066M |
| September 30, 2018 | -0.095M |
| June 30, 2018 | 11.51M |
| March 31, 2018 | 0.381M |
| December 31, 2017 | 4.827M |
| Date | Value |
|---|---|
| September 30, 2017 | -23.75M |
| June 30, 2017 | -0.09M |
| March 31, 2017 | 40.78M |
| December 31, 2016 | -0.232M |
| September 30, 2016 | -0.092M |
| June 30, 2016 | -0.117M |
| March 31, 2016 | -0.21M |
| December 31, 2015 | -0.04M |
| September 30, 2015 | -0.25M |
| June 30, 2015 | -0.382M |
| March 31, 2015 | -0.037M |
| December 31, 2014 | -0.19M |
| September 30, 2014 | -0.038M |
| June 30, 2014 | -0.061M |
| March 31, 2014 | -0.017M |
| December 31, 2013 | -0.118M |
| September 30, 2013 | -0.074M |
| June 30, 2013 | -0.242M |
| March 31, 2013 | -0.008M |
| December 31, 2012 | 0.023M |
| September 30, 2012 | -0.101M |
| June 30, 2012 | -0.184M |
| March 31, 2012 | -0.048M |
| December 31, 2011 | -0.012M |
| September 30, 2011 | -0.084M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.95M
Minimum
Jun 2021
5.484M
Maximum
Dec 2021
-1.106M
Average
-0.488M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Fonar Corp | -0.133M |
| XWELL Inc | 6.822M |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | -2.497M |
| OncoCyte Corp | 0.241M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.213M |
| Cash from Financing (Quarterly) | 2.924M |
| Free Cash Flow | -14.50M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow to Equity (Quarterly) | -4.482M |
| Free Cash Flow to Firm (Quarterly) | -1.182M |
| Free Cash Flow Yield | -16.58% |